Citations

Clear

33 citation(s) found for "Patel, Neal".

Risk of complications rise with coronary artery disease and diabetes mellitus after endobronchial valve placement in severe heterogeneous emphysema
Fernández-Bussy, Sebastián , Kornafeld, Anna , Labarca, Gonzalo , Patel, Neal M. , Johnson, Margaret M. , Reisenauer, Janani , Herth, Felix , Reisenauer, Janani S, Labarca, Gonzalo , Abia‐Trujillo, David

Mayo Clinic

The Clinical Respiratory Journal | July 24, 2021 | Volume: 15 | Issue: 11 | Pages: 1194-1200

10.1111/crj.13426 | PMID 34302313 Get It

AbstractBackgroundPatients with chronic obstructive pulmonary disease (COPD) commonly have comorbidities which may impact both symptoms and prognosis. Endoscopic lung volume reduction (ELVR) with endobronchial valves (EBV) is an innovative, effective and safe treatment for patients with severe emphysema who remain symptomatic despite optimal medical therapy.ObjectivesTo evaluate medical comorbidities associated with increased risk of complications after EBV procedure.MethodThis was a retrospective cohort review of patients with severe, heterogeneous emphysema who underwent Zephyr® EBV installation for ELVR. Demographics, baseline comorbidities, dyspnea scores, data regarding procedure, pulmonary function test, minimal clinically important difference and post‐EBV complications were recorded.ResultsOf a total 82 participants, 24 were identified as having a post procedure complication. There was a significant difference in the incidence of type 2 diabetes mellitus (T2DM) at baseline (25%) in complication group compared with non‐complication group (5.1%) (p value = 0.01). There was also a significant difference between baseline coronary artery disease (CAD) in those with (58.3%) or without (29.3%) complication (p = 0.01). Multivariate analysis of other covariables, identified associations of both CAD and T2DM with a heightened risk of complication (adjusted OR 4.19 CI: 1.23–14.2, p value = 0.02 and adjusted OR of 6.1 CI: 1.3–26.1, p value = 0.02 respectively).ConclusionsOur study found that patients with severe, heterogeneous emphysema who undergo ELVR utilizing Zephyr® EBV and suffer complications during post‐procedure period are more likely to have CAD or T2DM as baseline comorbidity. These data suggest that baseline CAD and T2DM might be predictive of increased risk of complications following ELVR with EBV.
Precautionary strategy for high‐risk airway bleeding cases during robotic‐assisted bronchoscopy
Fernández-Bussy, Sebastián , Abia‐Trujillo, David , Patel, Neal M. , Pascual, Jorge M., Majid, Adnan , Reisenauer, Janani , Reisenauer, Janani S, Abia-Trujillo, David , Folch, Erik E.

Mayo Clinic

Respirology Case Reports | June 11, 2021 | Volume: 9 | Issue: 7 | Pages: No page available

10.1002/rcr2.794 | PMID 34136261 Get It

AbstractBronchoscopy in thrombocytopenic patients remains a controversial topic as traditionally varying platelet thresholds have been stablished as “safe,” ranging from 20,000 to 50,000. A lower threshold may be safe for a routine airway inspection with bronchoalveolar lavage but will be far from safe for more invasive interventions such as needle biopsy, transbronchial biopsy, or cryo‐biopsy. Currently, a minimal platelet threshold during robotic‐assisted bronchoscopy (RAB) has not been established. In addition, the absolute platelet number does not guarantee appropriate platelet function. The literature regarding the safety of bronchoscopy and its bleeding risk, considering broader and more functional tests such as thromboelastography (TEG), is also lacking. We present our RAB approach to safely sample lung nodules in a patient with thrombocytopenia. Our precautionary strategy for high‐risk bleeding cases during RAB utilizing TEG and parallel flexible bronchoscopy with segmental balloon occlusion may be an appropriate technique to minimize bleeding risk.
Transbronchial Forceps Biopsy in the Intensive Care Unit
Burnside, Rebecca, Fernández-Bussy, Sebastián , Brigham, Tara , Patel, Neal M. , Brigham, Tara J, Brigham, T J , Helgeson, Scott A. , Imam, J. Saadi

Mayo Clinic

Journal of Bronchology & Interventional Pulmonology | March 24, 2021 | Volume: 28 | Issue: 4 | Pages: 281-289

10.1097/lbr.0000000000000767 | PMID 33758151 Get It

Background: A transbronchial forceps lung biopsy performed in mechanically ventilated patients with respiratory failure of unknown etiology has significant uncertainty of diagnostic yield and safety along with sparse literature. This study investigated the complication rate of transbronchial biopsies in mechanically ventilated patients in the intensive care unit and its ability to obtain a diagnosis and change current therapy. Methods: PubMed, Ovid MEDLINE, and Ovid Cochrane Central Register of Controlled Trials databases were systematically searched for all publications of transbronchial lung biopsies in mechanically ventilated patients. We pooled the results of individual studies using random-effects meta-analysis models to achieve the summary proportions. Results: Of the identified 9 observational studies with a total of 232 patients undergoing a transbronchial biopsy, complications occurred in 67 patients [25.2%; 95% confidence interval (CI), 11.5%-42.0%; I 2=70.0%]. Pneumothorax occurred in 24 patients (9.5%; 95% CI, 4.5%-16.2%; I 2=15.9%) and bleeding in 18 patients (8.9%; 95% CI, 4.1%-15.3%; I 2=0%). A diagnosis was given in 146 patients (62.9%; 95% CI, 56.0%-69.1%; I 2=74.6%), with 103 of 210 patients (49.0%; 95% CI, 44.6%-55.1%; I 2=74.9%) having a change in treatment. Conclusion: The results of this meta-analysis suggest that a transbronchial forceps biopsy when performed in mechanically ventilated patients with respiratory failure of unclear etiology had a moderate complication rate. These biopsies resulted in varied diagnoses with a high rate of management change. Randomized controlled trials are necessary to identify the ideal patients to perform a transbronchial forceps biopsy on in the intensive care unit.
Occult lymph node metastasis in radiologic stage I non‐small cell lung cancer: The role of endobronchial ultrasound
KUKHON, FAEQ R , Lan, Xinyue, Arunthari, Vichaya, Fernández-Bussy, Sebastián , Patel, Neal M. , Helgeson, Scott A.

Mayo Clinic

The Clinical Respiratory Journal | February 25, 2021 | Volume: 15 | Issue: 6 | Pages: 676-682

10.1111/crj.13344 | PMID 33630405 Get It

AbstractRationaleThe use of endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) is currently recommended for staging non‐small cell lung cancer (NSCLC) in centrally located tumors, tumors >3 cm, or with radiologic evidence of lymph node (LN) metastasis. Current guidelines do not recommend staging EBUS‐TBNA in patients with stage I NSCLC who do not have any of the aforementioned conditions.ObjectiveWe hypothesize that using EBUS‐TBNA is useful for detecting occult metastasis in radiologic stage I NSCLC.MethodsIn this single‐center, retrospective study, charts of patients ≥18 years old who underwent staging EBUS‐TBNA from January 2005 to May 2019 were reviewed. Only patients with combined positron‐emission tomography and computed tomography (PET/CT) scans consistent with radiologic stage I NSCLC were included. Identified variables included: age, gender, personal history of any cancer, smoking history, tumor location, tumor centrality, tumor size, tumor PET activity, histopathologic type of NSCLC, and LN biopsy results. Patients whose LN samples showed a diagnosis other than NSCLC were excluded. The association between LN positivity, and each of the variables was assessed using Pearson's correlation for categorical variables, and logistic regression analysis for continuous variables.ResultsFrom the 2,892 initially screened patients, 188 were included. Of those, 13 (6.9%; 95% CI, 4%–11%) had a malignancy‐positive LN biopsy. The number needed to test (NNT) in order to detect one case of any occult metastasis was 15. Among the included variables, a significant association was found between LN positivity and tumor centrality, with central tumors found in 61.5% of patients with positive LN (n = 8) (p < 0.01). This association stayed significant after adjusting for age, gender, smoking history, tumor size, tumor location, and PET activity (p = 0.015). Among patients with malignancy‐positive LN biopsies, five (38.5%; 95% CI, 17.6%–64.6%) were upstaged to N1, and eight (61.5%; 95% CI, 35.4%–82.4%) were upstaged to N2, with NNT of 23 to detect one case of occult N2 metastasis. Subgroup analysis comparing LN‐positive patients based on their N stage did not show statistically significant association with any of the variables.ConclusionBased on our results and along with the existing evidence, EBUS‐TBNA should be recommended as part of the routine staging in all patients with radiologic stage I NSCLC.
Aerosol Generation From a Simulated Air Leak
Lee, Augustine S. , Patel, Neal M. , Helgeson, Scott A. , Lim, Kaiser G. , Niven, Alexander S.

Mayo Clinic

Journal of Bronchology & Interventional Pulmonology | December 15, 2020 | Volume: 28 | Issue: 1 | Pages: 73-75

10.1097/lbr.0000000000000710 | PMID 33332846 Get It

Aerosol Generation during Spirometry
Helgeson, Scott A. , Lee, Augustine S. , Niven, Alexander S. , Patel, Neal M. , Niven, Alexander S , Helgeson, Scott A , Lim, Kaiser G.

Mayo Clinic

Annals of the American Thoracic Society | September 1, 2020 | Volume: 17 | Issue: 12 | Pages: 1637-1639

10.1513/annalsats.202005-569rl | PMID 32870021 Get It

Occult Lymph Node Metastasis in Radiographic Stage I Non-Small Cell Lung Cancer: The Role of Endobronchial Ultrasound Guided Biopsy
KUKHON, FAEQ R , Lan, Xinyue, Arunthari, Vichaya, Fernández-Bussy, Sebastián , Patel, Neal M. , Lan, X., Helgeson, Scott A.

Mayo Clinic

A110. ADVANCES IN INTERVENTIONAL PULMONOLOGY | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A2727-A2727

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2727 Get It

Clinical Outcomes of Patients with Sepsis in the Intensive Care Unit and Patient Reported Penicillin Allergy
Saunders, Hollie , Burnside, Rebecca, Patel, Neal M. , Helgeson, Scott A. , Harrison, Andrew M.

Mayo Clinic

B45. CRITICAL CARE: SEPSIS IDENTIFICATION AND MANAGEMENT | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A3508-A3508

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3508 Get It

Interventional Bronchoscopy
Criner, Gerard J. , Eberhardt, Ralf, Fernández-Bussy, Sebastián , Maldonado, Fabien , Patel, Neal M. , Shah, Pallav L. , Valipour, Arschang , Wahidi, Momen M. , Herth, Felix , Shah, Pallav L , Criner, Gerard , Eberhardt, Ralf , Gompelmann, Daniela , Slebos, Dirk‐Jan , Weir, Mark

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | February 5, 2020 | Volume: 202 | Issue: 1 | Pages: 29-50

10.1164/rccm.201907-1292so | PMID 32023078 Get It

Abstract For over 150 years, bronchoscopy, especially flexible bronchoscopy, has been a mainstay for airway inspection, the diagnosis of airway lesions, therapeutic aspiration of airway secretions, and transbronchial biopsy to diagnose parenchymal lung disorders. Its utility for the diagnosis of peripheral pulmonary nodules and therapeutic treatments besides aspiration of airway secretions, however, has been limited. Challenges to the wider use of flexible bronchoscopy have included difficulty in navigating to the lung periphery, the avoidance of vasculature structures when performing diagnostic biopsies, and the ability to biopsy a lesion under direct visualization. The last 10–15 years have seen major advances in thoracic imaging, navigational platforms to direct the bronchoscopist to lung lesions, and the ability to visualize lesions during biopsy. Moreover, multiple new techniques have either become recently available or are currently being investigated to treat a broad range of airway and lung parenchymal diseases, such as asthma, emphysema, and chronic bronchitis, or to alleviate recurrent exacerbations. New bronchoscopic therapies are also being investigated to not only diagnose, but possibly treat, malignant peripheral lung nodules. As a result, flexible bronchoscopy is now able to provide a new and expanding armamentarium of diagnostic and therapeutic tools to treat patients with a variety of lung diseases. This State-of-the-Art review succinctly reviews these techniques and provides clinicians an organized approach to their role in the diagnosis and treatment of a range of lung diseases.
A Single Center Experience of Pneumonitis After Immune Checkpoint Inhibitor Therapy
Heckman, Alexander , Kwon, Minji , Arunthari, Vichaya, Lou, Yanyan , Grage, Rolf A. , Rojas, Carlos A. , Patel, Neal M. , Kwon, M., Manochakian, Rami

Mayo Clinic

D24. AUTOIMMUNE DISEASE, DRUG-INDUCED, AND TRANSPLANT | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5968-A5968

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5968 Get It